‹ All rumors

Did NeuroXess raise about RMB 700 million in a Series B for fully implantable wireless BCI clinical trials and manufacturing?

UnconfirmedLast checked
NeuroXessFirst seen

Verdict

36Kr first-report of the Series B; term sheet and registry filings not re-opened in this run.

Evidence timeline · 1 source · newest first
  1. Unconfirmed

    36Kr reports that NeuroXess completed a RMB 700 million Series B led jointly by SDIC Juli, Shenzhen Capital Group, and Qinzhi Capital, with follow-ons from semiconductor and industrial investors. Funds are said to support multicenter trials and registration of a fully implantable, fully wireless, full-function BCI system, a super-factory, and BCI+AI R&D.

    Source: 36Kr
Quick answers
Has NeuroXess RMB 700M Series B confirmed it?
No. Neither NeuroXess RMB 700M Series B nor NeuroXess has confirmed it as of Oct 28.
How we label rumors
Unconfirmed
Circulating with at least one public source we can link to; no official confirmation.
Reported
Reported by a news outlet; not confirmed by the company.
Confirmed
Confirmed by the company or another official source.
Debunked
Denied by the company, retracted by the original source, or shown to be false by the evidence.

We record what sources show, with dates. We don't predict or score how likely a rumor is.

DailyCitedRSSAboutPrivacy